Bleich
Andrew Bleich, Palo Alto, CA US
Patent application number | Description | Published |
---|---|---|
20160118186 | Hardened Inductive Device And Systems And Methods For Protecting The Inductive Device From Catastrophic Events - A hardened inductive device and systems and methods for protecting the inductive device from impact is provided. The inductive device is hardened with protective coating and/or an armor steel housing. The hardened inductive device is protected from impact by an object such as a bullet and leakage of dielectric fluid is prevented. Acoustic and vibration sensors are provided to detect the presence and impact, respectively, of an object in relation to the inductive device housing. The measurements of the acoustic and vibration sensors are compared to thresholds for sending alarms to the network control center and initiating shut-down and other sequences to protect the active part. The acoustic sensor results are utilized to determine the location of origin of the projectile. | 04-28-2016 |
David Bleich, Westfield, NJ US
Patent application number | Description | Published |
---|---|---|
20090041751 | Sepsis Prevention Through Adenosine Receptor Modulation - Methods for treating sepsis or septic shock in a patient comprising administering to said patient a therapeutically effective amount of a composition containing an adenosine A | 02-12-2009 |
Jeffery L. Bleich, Mountain View, CA US
Patent application number | Description | Published |
---|---|---|
20090018507 | SPINAL ACCESS SYSTEM AND METHOD - Described herein are devices and systems for accessing a spine and particularly the epidural region of the spine and methods of using these systems and devices to access the spine or regions of the spine. In particular, cannulas that may be anchored to the ligamentum flavum or the periosteum are described. Ligamentum flavum access tools are also described. These tools may be used with (or without) an anchoring cannula to penetrate the ligamentum flavum and provide access to the epidural space without risk of injury to other structures within the epidural space. The devices, methods and systems described herein are particularly useful in minimally invasive surgical (MIS) uses. The devices, methods and systems described herein may be used for performing spinal decompressions and other spinal procedures. | 01-15-2009 |
Jeffery Lee Bleich, Palo Alto, CA US
Patent application number | Description | Published |
---|---|---|
20130171599 | System and Method for Reliably Coordinating Musculoskeletal and Cardiovascular Hemodynamics - Systems and methods are disclosed to enable a user to favorably coordinate the timing of musculoskeletal movement and skeletal muscle contraction and relaxation with the cardiac pumping cycle in order to improve perfusion of cardiac and peripheral skeletal muscle and other tissues, increase physiological efficiency, decrease myocardial stress, and enhance individual performance, health and safety during rhythmic physical activity. Additionally, systems and methods are disclosed to enable a user to avoid inadvertent unfavorable coordination of musculoskeletal movement and skeletal muscle contractions and relaxation cycles with the cardiac pumping cycle during physical activity. | 07-04-2013 |
Jeffrey L. Bleich, Palo Alto, CA US
Patent application number | Description | Published |
---|---|---|
20110004207 | Flexible Neural Localization Devices and Methods - Described herein are devices, systems and methods for determining if a nerve is nearby a device or portion of a device. The neural stimulation tools described herein are configured to be flexible and low-profile, so that they can be used within body regions that may be tortuous or difficult to reach, such as within a compressed or partially occluded neural foramen. In most cases, these tools described herein are ribbon-shaped and adapted to be manipulated bimanually, for example, by applying force to the ends of the devices from separate locations outside of the patient's body. Thus, in some of the exemplary neural localization devices described herein, the distal end region of the device are configured to couple to the proximal end of a guidewire. One or more surfaces of the devices may include an electrode or multi-polar network of electrodes configured to stimulate only nerves within a predetermined distance of a particular face of the device. | 01-06-2011 |
Larry Lynn Bleich, Hickory, NC US
Patent application number | Description | Published |
---|---|---|
20110147249 | REEL-IN-BOX CABLE PACKAGE - A communications cable reel package includes a box having a bottom, first, second, third and fourth side walls, and a top, wherein the first and second side walls are opposing side walls, and wherein each of the first and second side walls includes a slot with an open upper end. The package further comprises: an axle member mounted in the slots; a spool mounted on the axle member; and communications cable wound onto the spool. | 06-23-2011 |
20140284072 | Chain Extended Foam Insulation Coaxial Cable and Method of Manufacture - A method for manufacturing a coaxial cable werein a polymer is irradiated and extruded around a metallic inner conductor and the polymer is then surrounded with a metallic outer conductor. The irradiated polymer may be irradiated, for example, via electron beam, for example, between 0.25 and 4 MRad. | 09-25-2014 |
Markus Bleich, Hunfelden-Dauborn DE
Patent application number | Description | Published |
---|---|---|
20090137630 | SUBSTITUTED THIOPHENES: COMPOSITIONS, PROCESSES OF MAKING, AND USES IN DISEASE TREATMENT AND DIAGNOSIS - The present invention comprises compounds and compositions comprising substituted thiophene derivatives with the following backbone structure: | 05-28-2009 |
Stefan Bleich, Uetze (ot Obershagen) DE
Patent application number | Description | Published |
---|---|---|
20150184242 | SUSCEPTIBILITY TO AND STRATIFICATION FOR MONOAMINERGIC ANTIDEPRESSANTS - The present invention relates to a method for predicting the non-response or response to a monoaminergic antidepressant of a patient to be treated with a monoaminergic antidepressant comprising the steps: (i) determining the DNA-methylation status of a brain-derived neurotrophic factor (BDNF)-gene promoter in a sample of said patient; (ii) attributing a hypomethylation of said BDNF-gene promoter to the non-response to a monoaminergic antidepressant of said patient; and (iii) attributing normal methylation or hypermethylation of said BDNF-gene promoter to the response to a monoaminergic antidepressant of said patient. Furthermore, a kit and the use of a kit in said method is disclosed. | 07-02-2015 |